Financhill
Buy
58

CRVO Quote, Financials, Valuation and Earnings

Last price:
$14.50
Seasonality move :
9.13%
Day range:
$12.05 - $16.94
52-week range:
$1.80 - $25.92
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
168.72x
P/B ratio:
3.22x
Volume:
7.3M
Avg. volume:
8.9M
1-year change:
-35.39%
Market cap:
$126.4M
Revenue:
--
EPS (TTM):
-$2.03

CRVO Analysts' Consensus Rating

The 6 analysts providing 12-month price projections for CervoMed shares anticipate an average target of $15.83, ranging from a low estimate of $10.00 to a high estimate of $21.00. This average target implies a growth of 9.01% compared to the current stock price of $14.53.

Consensus Price Target

$15.83

Highest Price Target

$21.00

Lowest Price Target

$10.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 4 2 5

Hold 0 4 1

Sell 0 1 0
Consensus Buy Hold Buy

CRVO Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Tenable Stock a Buy, Sell or Hold?
Is Tenable Stock a Buy, Sell or Hold?

Tenable (NASDAQ:TENB) is a cybersecurity company with a focus on…

Is CyberArk Stock a Buy, Sell or Hold?
Is CyberArk Stock a Buy, Sell or Hold?

CyberArk Software (NASDAQ:CYBR), the identity security and management firm, has…

Is Amazon Stock Still Worth Staking On?
Is Amazon Stock Still Worth Staking On?

Amazon.com Inc (NASDAQ: AMZN) posted one of its strongest years…

Stock Ideas

Buy
55
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 36x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Alerts

Sell
50
RGC alert for Mar 22

Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.

Sell
36
VMI alert for Mar 22

Valmont Industries [VMI] is down 12.54% over the past day.

Buy
61
ALNY alert for Mar 22

Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock